ZYDUS LIFESCIENCES
Back to Balance Sheet
|
ZYDUS LIFESCIENCES Last 5 Year Total Non-Current Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹193 Cr | ₹-725 Cr | ₹-194 Cr | ₹19 Cr | ₹2,854 Cr |
What is the latest Total Non-Current Liabilities ratio of ZYDUS LIFESCIENCES ?
Year | Total Non-Current Liabilities |
---|---|
Mar2024 | ₹193 Cr |
Mar2023 | ₹-725 Cr |
Mar2022 | ₹-194 Cr |
Mar2021 | ₹19 Cr |
Mar2020 | ₹2,854 Cr |
How is Total Non-Current Liabilities of ZYDUS LIFESCIENCES Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹193 Cr | Positive | |
Mar2023 | ₹-725 Cr | Negative | |
Mar2022 | ₹-194 Cr | Negative | |
Mar2021 | ₹19 Cr | -99.32 | |
Mar2020 | ₹2,854 Cr | - |
Compare Total Non-Current Liabilities of peers of ZYDUS LIFESCIENCES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
ZYDUS LIFESCIENCES | ₹98,567.4 Cr | -1.9% | 0.1% | -16.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹401,289.0 Cr | -0.4% | -0.9% | 4.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹181,397.0 Cr | -0.7% | 1.6% | 50.2% | Stock Analytics | |
CIPLA | ₹119,955.0 Cr | -1.7% | -1.1% | -2.3% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹112,132.0 Cr | -1.1% | 1.6% | 13.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,657.0 Cr | -4.3% | -8% | -4.4% | Stock Analytics |
ZYDUS LIFESCIENCES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ZYDUS LIFESCIENCES | -1.9% |
0.1% |
-16.5% |
SENSEX | -1.1% |
-0% |
3.2% |
You may also like the below Video Courses